Sepúlveda Rodrigo A, Anghileri Fiorella, Huidobro E Juan Pablo, Julio Rodrigo, Ávila Eduardo, Figueroa Cristián
Nephrology Department, School of Medicine, Pontificia Universidad Católica de Chile, and.
Clinical Laboratories Department, Hospital Clínico Red de Salud UC-Christus, Santiago, Chile.
Clin Nephrol Case Stud. 2022 Sep 23;10:71-75. doi: 10.5414/CNCS110931. eCollection 2022.
Management of acute kidney injury (AKI) associated with drug-induced crystal nephropathy can be difficult, and timely diagnosis is critical to resolve this condition. We present the case of a 55-year-old woman with history of systemic lupus erythematosus (SLE), who, after treatment with trimethoprim/sulfamethoxazole (TMP/SMX) for suspected pneumonia, developed severe AKI. Automated urinary sediment initially reported hematuria, leukocyturia and "uric acid crystals". She did not have allergic symptoms, clinical manifestations of active SLE nor hyperuricemia. AKI persisted despite volume expansion with crystalloids. Due to SMX exposure, it was suspected that "uric acid crystals" could be in reality "SMX crystals", and were a possible cause of crystal nephropathy. TMP/SMX was withheld and urinary alkalization was performed, with subsequent resolution of AKI. SMX urine crystals were posteriorly confirmed by Fourier transform infrared spectroscopy.
药物性结晶肾病相关急性肾损伤(AKI)的管理可能具有挑战性,及时诊断对于解决这种情况至关重要。我们报告了一例55岁有系统性红斑狼疮(SLE)病史的女性病例,该患者在因疑似肺炎接受甲氧苄啶/磺胺甲恶唑(TMP/SMX)治疗后,发生了严重的AKI。自动尿沉渣最初报告有血尿、白细胞尿和“尿酸结晶”。她没有过敏症状、活动性SLE的临床表现,也没有高尿酸血症。尽管使用晶体液进行了容量扩充,但AKI仍持续存在。由于接触了SMX,怀疑“尿酸结晶”实际上可能是“SMX结晶”,并且是结晶肾病的一个可能原因。停用了TMP/SMX并进行了尿液碱化,随后AKI得到缓解。SMX尿结晶随后通过傅里叶变换红外光谱法得到证实。